Inventor · disambiguated record
Christian W. Siebel
Also filed as: SIEBEL CHRISTIAN · SIEBEL CHRISTIAN W
19 granted patents·5 pending applications·72 citations·filing 2001–2024
93Inventor score
Top patents by PatentIndex Score
24 records- 0190US9550829B2Compositions and methods for diagnosis and treatment of hepatic cancersGENENTECH INC·Filed 2014·Granted Jan 24, 2017·14 cites·17 claims
- 0288US9518121B2Anti-Jagged1 antibodies and methods of useGENENTECH INC·Filed 2015·Granted Dec 13, 2016·7 cites·38 claims
- 0387US9982058B2Anti-JAG1 antibody compositions and methods for treatment of hepatic cancersGENENTECH INC·Filed 2016·Granted May 29, 2018·6 cites·18 claims
- 0486US10689455B2Anti-jagged antibodies and methods of useGENENTECH INC·Filed 2018·Granted Jun 23, 2020·2 cites·16 claims
- 0586US10011661B2Anti-Jagged1 antibodies and methods of useGENENTECH INC·Filed 2016·Granted Jul 3, 2018·5 cites·37 claims
- 0686US8404239B2Anti-Notch2 NRR antibodiesSIEBEL CHRISTIAN W·Filed 2009·Granted Mar 26, 2013·7 cites·48 claims
- 0785US8846871B2Anti-Notch1 NRR antibodiesSIEBEL CHRISTIAN W·Filed 2008·Granted Sep 30, 2014·6 cites·53 claims
- 0884US9914774B2Notch pathway inhibitionGENENTECH INC·Filed 2015·Granted Mar 13, 2018·7 cites·37 claims
- 0983US10113002B2Anti-jagged antibodies and methods of useGENENTECH INC·Filed 2013·Granted Oct 30, 2018·4 cites·21 claims
- 1082US9200071B2Methods of treating cancer using Notch1 and Notch3 antagonistsSIEBEL CHRISTIAN W·Filed 2010·Granted Dec 1, 2015·7 cites·16 claims
- 1181US10005844B2Polynucleotides encoding anti-Notch1 NRR antibody polypeptidesGENENTECH INC·Filed 2017·Granted Jun 26, 2018·2 cites·10 claims
- 1281US2024384000A1Anti-Jagged1 Antibodies and Methods of UseGENENTECH INC·Filed 2024·Application pending·0 cites
- 1381US2024034805A1Anti-Jagged Antibodies and Methods of UseGENENTECH INC·Filed 2023·Application pending·0 cites
- 1475US9663573B2Methods of treating liver conditions using Notch2 antagonistsFRENCH DOROTHY·Filed 2012·Granted May 30, 2017·2 cites·12 claims
- 1573US6929909B2Gene targeting vectors comprising conditional positive selection markersDELTAGEN INC·Filed 2001·Granted Aug 16, 2005·3 cites·27 claims
- 1672US11702479B2Anti-jagged antibodies and methods of useGENENTECH INC·Filed 2020·Granted Jul 18, 2023·0 cites·28 claims
- 1769US11926674B2Anti-Jagged2 antibodies and methods of useGENENTECH INC·Filed 2020·Granted Mar 12, 2024·0 cites·9 claims
- 1864US10858440B2Anti-Jagged1 antibodies and methods of useGENENTECH INC·Filed 2018·Granted Dec 8, 2020·0 cites·32 claims
- 1963US9533042B2Anti-notch NRR antibodies and methods using sameGENENTECH INC·Filed 2014·Granted Jan 3, 2017·0 cites·28 claims
- 2062US2017204175A9Anti-notch2 nrr antibodiesGENENTECH INC·Filed 2014·Application pending·0 cites
- 2161US10266602B2Compositions and methods for diagnosis and treatment of hepatic cancersGENENTECH INC·Filed 2018·Granted Apr 23, 2019·0 cites·20 claims
- 2260US2018057589A1Anti-notch2 nrr antibodiesGENENTECH INC·Filed 2017·Application pending·0 cites
- 2359US10208114B2Methods of treating liver conditions using Notch2 antagonistsGENENTECH INC·Filed 2017·Granted Feb 19, 2019·0 cites·8 claims
- 2455US2017233486A1Polynucleotides encoding anti-notch1 nrr antibody polypeptidesGENENTECH INC·Filed 2016·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →